Skip to main content
Premium Trial:

Request an Annual Quote

VizX Labs Sells GeneSifter Microarray Analysis Software to Labs in US, UK, and Australia

NEW YORK, Sept. 6 (GenomeWeb News) - VizX Labs has recently sold its microarray data-analysis software to academic groups in the US, the UK, and Australia, the Seattle-based bioinformatics company said today.


Among the new customers of VizX's GeneSifter software are groups at the Oregon Cancer Institute, the Universityof Leeds, the SidneyKimmelCancerCenter, the Baylor University School of Medicine, the Mount Sinai School of Medicine, and the Universityof Western Australia.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.